1. Home
  2. PBPB vs TNXP Comparison

PBPB vs TNXP Comparison

Compare PBPB & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBPB
  • TNXP
  • Stock Information
  • Founded
  • PBPB 1977
  • TNXP 2007
  • Country
  • PBPB United States
  • TNXP United States
  • Employees
  • PBPB N/A
  • TNXP N/A
  • Industry
  • PBPB Restaurants
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBPB Consumer Discretionary
  • TNXP Health Care
  • Exchange
  • PBPB Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • PBPB 305.0M
  • TNXP 272.0M
  • IPO Year
  • PBPB 2013
  • TNXP N/A
  • Fundamental
  • Price
  • PBPB $12.77
  • TNXP $35.48
  • Analyst Decision
  • PBPB Strong Buy
  • TNXP Strong Buy
  • Analyst Count
  • PBPB 3
  • TNXP 2
  • Target Price
  • PBPB $15.67
  • TNXP $585.00
  • AVG Volume (30 Days)
  • PBPB 243.5K
  • TNXP 729.5K
  • Earning Date
  • PBPB 08-07-2025
  • TNXP 08-15-2025
  • Dividend Yield
  • PBPB N/A
  • TNXP N/A
  • EPS Growth
  • PBPB 1009.90
  • TNXP N/A
  • EPS
  • PBPB 1.39
  • TNXP N/A
  • Revenue
  • PBPB $465,126,000.00
  • TNXP $10,041,000.00
  • Revenue This Year
  • PBPB $4.74
  • TNXP $11.66
  • Revenue Next Year
  • PBPB $4.48
  • TNXP $793.18
  • P/E Ratio
  • PBPB $9.18
  • TNXP N/A
  • Revenue Growth
  • PBPB N/A
  • TNXP N/A
  • 52 Week Low
  • PBPB $6.28
  • TNXP $6.76
  • 52 Week High
  • PBPB $13.48
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • PBPB 71.00
  • TNXP 52.96
  • Support Level
  • PBPB $11.83
  • TNXP $33.71
  • Resistance Level
  • PBPB $12.65
  • TNXP $38.13
  • Average True Range (ATR)
  • PBPB 0.43
  • TNXP 2.62
  • MACD
  • PBPB 0.06
  • TNXP -0.44
  • Stochastic Oscillator
  • PBPB 93.46
  • TNXP 61.01

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: